Additionally, leptin-receptor expression was compatible with poor survival outcome in 160 (47%) patients with lymph node metastasis, on univariate and multivariate analysis (P < 0.05) (Fig 2D). This evidence concerns the gene LEPR and metastatic malignant neoplasm in the lymph nodes.